Fulminant ulcerative colitis complicated by treatment-refractory bacteremia.
Severe ulcerative colitis is defined by more than six bloody stools daily and evidence of toxicity, demonstrated by fever, tachycardia, anemia, or an elevated erythrocyte sedimentation rate. Fulminant disease represents a subset of severe disease with signs and symptoms suggestive of increased toxicity. Treatment of severe colitis includes intravenous corticosteroid administration, with consideration of intravenous infliximab 5 mg/kg. Failure to show improvement after 3 to 5 days is an indication for colectomy or treatment with intravenous cyclosporine. We report a 23-year-old Hispanic woman with decompensated cirrhosis presenting with new-onset fulminant ulcerative colitis and resulting polymicrobial bacteremia, requiring colectomy for infection source control and colitis treatment.
Department of Internal Medicine (Krease, Stroup, Som) and Division of Gastroenterology (Shepard), Oklahoma State University Medical Center, Tulsa, Oklahoma.
Michael
M
Krease
Department of Internal Medicine (Krease, Stroup, Som) and Division of Gastroenterology (Shepard), Oklahoma State University Medical Center, Tulsa, Oklahoma.
Jeff
J
Stroup
Department of Internal Medicine (Krease, Stroup, Som) and Division of Gastroenterology (Shepard), Oklahoma State University Medical Center, Tulsa, Oklahoma.
Mousumi
M
Som
Department of Internal Medicine (Krease, Stroup, Som) and Division of Gastroenterology (Shepard), Oklahoma State University Medical Center, Tulsa, Oklahoma.
Benjamin
B
Shepard
Clin Infect Dis. 2002 Jul 1;35(1):1-10
12060868
Hepatology. 2005 Mar;41(3):422-33
15723320
Hepatology. 2009 Jun;49(6):2087-107
19475696
Am J Gastroenterol. 2010 Mar;105(3):501-23; quiz 524
20068560